Cisplatin and carboplatin in combination for the treatment of stage IV ovarian carcinoma

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

1989 • 1,831 citations

The importance of dose intensity in chemotherapy of metastatic breast cancer.

1984 • 882 citations

Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.

1987 • 385 citations

High-Dose Cisplatin in Hypertonic Saline

1984 • 335 citations

High-dose cisplatin in hypertonic saline in refractory ovarian cancer.

1985 • 225 citations

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.

1989 • 190 citations

A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.

1983 • 181 citations

High-dose carboplatin in refractory ovarian cancer patients.

1987 • 151 citations

Ovarian trials at the Royal Marsden

1985 • 110 citations

High-dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual disease.

1989 • 71 citations

High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation study

1987 • 71 citations

A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma.

1986 • 68 citations

USE OF HIGH DOSE CIS‐DICHLORODIAMMINE PLATINUM (II) (NSC—119875)^† FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED CARCINOMA OF THE OVARY

1981 • 64 citations

Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion.

1987 • 57 citations

NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER

1990 • 1 citations